TianYu Bio-Technology Co., Ltd. (SHA:603717)
China · Delayed Price · Currency is CNY 6.38
+0.13 (2.08%)
Aug 17, 2026, 3:00 PM CST
TianYu Bio-Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,851 | 2,275 | 2,336 | 2,231 | 1,996 | 3,708 | |
Market Cap Growth | -19.44% | -2.61% | 4.68% | 11.77% | -46.17% | 80.42% |
Enterprise Value | 2,954 | 3,405 | 3,420 | 3,522 | 3,118 | 4,345 |
Last Close Price | 6.38 | 7.84 | 8.05 | 7.69 | 6.88 | 12.78 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 15.36 | 15.36 | 15.36 | 15.36 | 15.36 |
PS Ratio | 2.83 | 3.14 | 2.91 | 3.33 | 2.11 | 5.81 |
PB Ratio | 3.15 | 3.83 | 3.30 | 2.67 | 1.39 | 2.30 |
P/TBV Ratio | 5.20 | 5.90 | 4.76 | 3.53 | 1.77 | 2.84 |
P/FCF Ratio | 15.07 | 11.11 | 28.74 | - | 89.94 | - |
P/OCF Ratio | 10.89 | 8.81 | 17.27 | - | 18.92 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.52 | 4.69 | 4.27 | 5.25 | 3.30 | 6.81 |
EV/FCF Ratio | 24.05 | 16.63 | 42.08 | - | 140.48 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.75 | 1.87 | 1.81 | 1.56 | 0.76 | 0.49 |
Debt / FCF Ratio | 8.39 | 5.41 | 15.75 | - | 48.88 | - |
Net Debt / Equity Ratio | 1.53 | 1.61 | 1.56 | 1.38 | 0.56 | 0.30 |
Net Debt / EBITDA Ratio | -8.91 | -11.65 | -29.17 | -2.87 | -3.13 | -2.18 |
Net Debt / FCF Ratio | 7.31 | 4.66 | 13.56 | -4.43 | 35.92 | -2.09 |
Asset Turnover | 0.22 | 0.24 | 0.25 | 0.20 | 0.28 | 0.19 |
Inventory Turnover | 3.20 | 3.37 | 3.82 | 4.96 | 4.97 | 6.53 |
Quick Ratio | 0.50 | 0.65 | 0.87 | 1.09 | 1.43 | 1.39 |
Current Ratio | 0.89 | 0.85 | 1.08 | 1.31 | 1.69 | 1.56 |
Return on Equity (ROE) | -20.51% | -15.67% | -11.26% | -49.90% | -15.48% | -14.84% |
Return on Assets (ROA) | -3.02% | -2.53% | -1.46% | -8.06% | -4.95% | -4.41% |
Return on Invested Capital (ROIC) | -9.45% | -7.36% | -3.99% | -20.60% | -12.45% | -11.11% |
Return on Capital Employed (ROCE) | -8.70% | -7.90% | -4.10% | -21.40% | -11.50% | -12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -7.09% | -4.70% | -4.60% | -20.69% | -14.00% | -5.79% |
FCF Yield | 6.64% | 9.00% | 3.48% | -11.67% | 1.11% | -6.21% |
Buyback Yield / Dilution | -0.04% | -0.01% | 0.00% | -19.99% | 9.09% | -9.99% |
Total Shareholder Return | -0.04% | -0.01% | - | -19.99% | 9.09% | -9.99% |